Qinecsa, the global pharmacovigilance specialist, has been selected as technology partner for AfriVigilance, the African Medicines Agency’s (AMA) new continent-wide ...

AstraZeneca’s Etcamah has received FDA accelerated approval for ctDNA-guided treatment in HR-positive, HER2-negative breast cancer with ESR1 mutations. The decision ...

CluePoints, the premier provider of Risk-Based Quality Management (RBQM) and clinical data quality oversight software, today announced the general availability of th...

Growing demand for biologics, advanced therapies and specialist aseptic fill-finish expertise is driving continued expansion across the pharmaceutical outsourcing se...

Inceptua Group (Inceptua) and TikoMed AB (TikoMed) have announced the launch of a Named Patient Programme for TikoMed’s investigational drug, ILB®, for eligible pati...

Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, and Ansa Biotechnologies, Inc., a trusted partner for DNA synthesis, today anno...

New START site to be established within AHN Cancer Centre will integrate novel oncology research therapies closer to patients across Western Pennsylvania. Alleghe...

Eli Lilly and Company has announced a definitive agreement to acquire clinical-stage biotechnology company AtaiBeckley in a deal valued at up to $3.8 billion, includ...

Healthcare consultancy Prescient Healthcare Group has completed the integration of recently acquired businesses Uptake and Dolon under a single global Prescient bran...

ECI announced today that its Product & Packaging Testing Laboratory, located in the Coyol Free Zone in Costa Rica, has achieved ISO/IEC 17025:2017 accreditation ...